Inventage Lab Inc.
Biopharmaceutical company developing advanced drug delivery systems.
389470 | KO
Overview
Corporate Details
- ISIN(s):
- KR7389470006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로388번길 24, 101호, 601호, 612호, 성남시
Description
Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-25 00:00 |
투자판단관련주요경영사항(알코올 의존성 및 opioid 의존성 치료제(IVL3004) 호주 임상 제1상 HREC 시험계획 승인)
|
Korean | 9.7 KB | ||
| 2023-01-05 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 140.1 KB | ||
| 2023-01-02 00:00 |
기타경영사항(자율공시)(특허권 취득)
|
Korean | 5.4 KB | ||
| 2023-01-02 00:00 |
[기재정정]기타경영사항(자율공시)(특허권 취득)
|
Korean | 9.3 KB | ||
| 2022-12-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-12-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-12-27 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 144.5 KB | ||
| 2022-12-20 00:00 |
주식매수선택권행사
|
Korean | 31.6 KB | ||
| 2022-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2022-12-08 00:00 |
투자판단관련주요경영사항(알코올 의존성 및 opioid 의존성 치료제(IVL3004) 호주 임상 제1상 시험계획 신청)
|
Korean | 9.5 KB | ||
| 2022-12-05 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 66.8 KB | ||
| 2022-12-05 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.7 KB | ||
| 2022-11-29 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 165.9 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB |
Automate Your Workflow. Get a real-time feed of all Inventage Lab Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inventage Lab Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inventage Lab Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
